,DRUG_NAME,STRUCT_ID,TARGET_NAME,TARGET_CLASS,ACCESSION,GENE,SWISSPROT,ACT_VALUE,ACT_UNIT,ACT_TYPE,ACT_COMMENT,ACT_SOURCE,RELATION,MOA,MOA_SOURCE,ACT_SOURCE_URL,MOA_SOURCE_URL,ACTION_TYPE,TDL,ORGANISM,NEW_ID
8,(S)-nicardipine,5,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1.0,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022276s003lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022276s003lbl.pdf,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
10,(S)-nitrendipine,6,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,8.4,,IC50,Recombinant Cav1.3 calcium channel complexes expressed in tsA-cells,IUPHAR,=,1.0,IUPHAR,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL251230,GATING INHIBITOR,Tclin,Homo sapiens,HGNC:1391
11,(S)-nitrendipine,6,Voltage-dependent L-type calcium channel subunit alpha-1F,Ion channel,O60840,CACNA1F,CAC1F_HUMAN,6.0,,IC50,,IUPHAR,~,,,,,GATING INHIBITOR,Tclin,Homo sapiens,HGNC:1393
12,(S)-nitrendipine,6,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P22002,Cacna1c,CAC1C_RAT,6.0,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,,Rattus norvegicus,RGD:2245
13,(S)-nitrendipine,6,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,Q02485,Cacna1s,CAC1S_RAT,6.0,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,,Rattus norvegicus,RGD:70983
14,(S)-nitrendipine,6,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/17276408,BLOCKER,Tclin,Homo sapiens,HGNC:1390
22,phenylbutanoic acid,24,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,4.19,,IC50,Inhibition of human recombinant HDAC2,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:4853
157,acetylcholine,65,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.11,,EC50,Activation of M1-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as FRET signal,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
172,acetylcholine,65,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,7.92,,IC50,Compound was tested in vitro for its binding affinity to muscarinic acetylcholine receptor from rat cortical homogenates using [3H]OXO-M as radioligand,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
182,acepromazine,73,Major prion protein,Surface antigen,P04156,PRNP,PRIO_HUMAN,5.3,,EC50,Half maximal inhibition of Prion protein PrPsc formation was assayed in ScN2a cells,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:9449
270,adenosine phosphate,92,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,7.0,,IC50,Inhibition of p60c-src expressed in chick embryo fibroblast,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
283,adiphenine,94,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,7.45,,Kd,Affinity for the Muscarinic acetylcholine receptor,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
308,alcuronium,109,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.0,,Kd,,IUPHAR,=,,,,,ALLOSTERIC MODULATOR,Tclin,Homo sapiens,HGNC:1950
315,alcuronium,109,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
501,amiodarone,176,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.2010000000000005,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
572,amitriptyline,180,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.83,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
599,amitriptyline,180,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,6.52,,IC50,Inhibition of radioligand [3H]QNB binding to muscarinic acetylcholine receptor in the rat forebrain in the presence of zinc,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
615,amlodipine,183,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1491,BLOCKER,Tclin,Homo sapiens,HGNC:1390
618,amlodipine,183,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,7.0,,Ki,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1491,BLOCKER,Tclin,Homo sapiens,HGNC:1391
621,amlodipine,183,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P22002,Cacna1c,CAC1C_RAT,8.7,,Ki,Binding affinity against rat L-type calcium channel,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2245
626,amodiaquine,186,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,5.4,,IC50,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,CHEMBL,=,,,,,,,Homo sapiens,HGNC:620
642,amoxapine,191,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.5420000000000025,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
733,octatropine methylbromide,223,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,DRUGBANK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1578,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
792,aprindine,231,Sodium/calcium exchanger 1,Transporter,P32418,SLC8A1,NAC1_HUMAN,4.301,,IC50,,WOMBAT-PK,=,,,,,,Tbio,Homo sapiens,HGNC:11068
795,aranidipine,234,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1.0,KEGG DRUG,,http://www.kegg.jp/entry/D01562,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
821,aripiprazole,242,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.169,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
871,astemizole,249,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.59,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
944,atorvastatin,257,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,4.65,,IC50,Inhibition of recombinant HDAC2 (unknown origin) after 10 mins by fluorimetric analysis,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:4853
957,atracurium,259,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.77,,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1360,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
964,atropine,260,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.31,,Ki,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
972,atropine,260,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,9.59,,Ki,Ability to displace [3H]pirenzepine (PZ) from M1 receptor in rat cortex homogenate,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
981,atropine,260,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,9.52,,Ki,The compound was tested for inhibition of [3H]NMS binding against muscarinic acetylcholine receptor in rat brain,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
993,azathioprine,269,Ras-related C3 botulinum toxin substrate 1,Enzyme,P63000,RAC1,RAC1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tbio,Homo sapiens,HGNC:9801
1002,azelastine,271,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.2,,IC50,Displacement of [3H]AF-DX 384 from recombinant human M1 receptor expressed in CHO cells,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
1006,azelnidipine,272,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1.0,KEGG DRUG,,http://www.kegg.jp/entry/D01145,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
1046,barnidipine,290,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1.0,KEGG DRUG,,http://www.kegg.jp/entry/D07494,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
1062,bendamustine,302,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,8.05,,IC50,,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:4853
1072,bendroflumethiazide,305,Calcium-activated potassium channel subunit alpha-1,Ion channel,Q12791,KCNMA1,KCMA1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:6284
1085,diphenidol,313,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.108,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL936,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
1107,benzbromarone,318,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,4.27,,IC50,Inhibition of PTP1B (unknown origin) by p-nitrophenylphosphate assay,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:9642
1145,benzthiazide,332,Calcium-activated potassium channel subunit alpha-1,Ion channel,Q12791,KCNMA1,KCMA1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:6284
1158,benzatropine,333,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.636000000000001,,Ki,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201203,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
1170,benzatropine,333,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,9.23,,Ki,Displacement of [3H]pirenzepine binding at Muscarinic acetylcholine receptor M1 in rat brain P2 membranes.,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
1187,bepridil,342,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/1281221,https://pubmed.ncbi.nlm.nih.gov/1281221,BLOCKER,Tclin,Homo sapiens,HGNC:1390
1188,bepridil,342,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/1281221,https://pubmed.ncbi.nlm.nih.gov/1281221,BLOCKER,Tclin,Homo sapiens,HGNC:1391
1213,bethanechol,358,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,4.0,,Ki,,IUPHAR,=,,,,,AGONIST,Tclin,Homo sapiens,HGNC:1950
1262,biperiden,374,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.32,,Kd,,IUPHAR,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1101,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
1317,bortezomib,391,Proteasome subunit beta type-5,Enzyme,P28074,PSMB5,PSB5_HUMAN,9.26,,Ki,Inhibition of 20S proteasome beta5 subunit (unknown origin) assessed as formation of reversible adduct with N-terminal threonine,CHEMBL,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041,INHIBITOR,Tclin,Homo sapiens,HGNC:9542
1441,bromperidol,407,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.119,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
1588,scopolamine butylbromide,458,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1950
1609,cadralazine,461,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1390
1686,caramiphen,486,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.92,,Ki,Displacement of [3H]pirenzepine from muscarinic acetylcholine receptor M1 in rat cortex homogenates,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
1694,carbachol,488,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.523,,EC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
1701,carbachol,488,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,7.51,,Ki,"Affinity versus [3H]oxotremorine M (agonist) binding to Muscarinic acetylcholine receptor M1 in Rat Cerebral Cortical Membranes, (Kd=0.75 nM)",CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
1704,carbachol,488,Muscarinic acetylcholine receptor M1,GPCR,P12657,Chrm1,ACM1_MOUSE,7.7,,Ki,Binding affinity (low) of [3H](R)-QNB binding to Muscarinic acetylcholine receptor M1 expressed in A9 L cell line in the absence of 300 uM GTP-gamma-S,CHEMBL,=,,,,,,,Mus musculus,MGI:88396
1715,carbachol,488,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,8.89,,Ki,In vitro binding affinity for muscarinic receptor by displacing [3H]oxotremorine-M binding on rat brain homogenate.,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
1725,carbenicillin,492,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.37,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
1733,pentoxyverine,494,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.12,,Ki,Binding affinity towards muscarinic m1 receptor,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
1810,carvedilol,522,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,4.52,,IC50,,CHEMBL,=,,,,,,,Homo sapiens,HGNC:620
2017,cevimeline,584,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.638,,EC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL168815,AGONIST,Tclin,Homo sapiens,HGNC:1950
2065,chloropyramine,606,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,6.24,,Kd,Binding affinity to biotinylated human FAK FAT domain by biolayer interoferometry,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:9611
2070,chloroquine,607,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.04,,Ki,Activity of compound against Muscarinic acetylcholine receptor M1 (CHRM1) by displacement of 3H-QNB,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
2078,chloroquine,607,Major prion protein,Surface antigen,P04156,PRNP,PRIO_HUMAN,5.4,,EC50,Half maximal inhibition of Prion protein PrPsc formation was assayed in ScN2a cells,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:9449
2082,chloroquine,607,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,5.16,,IC50,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,CHEMBL,=,,,,,,,Homo sapiens,HGNC:620
2136,chlorpromazine,621,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.602,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
2161,chlorpromazine,621,Major prion protein,Surface antigen,P04156,PRNP,PRIO_HUMAN,5.7,,EC50,Half maximal inhibition of Prion protein PrPsc formation was assayed in ScN2a cells,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:9449
2187,chlorpromazine,621,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,7.22,,Ki,In vitro binding affinity against Muscarinic acetylcholine receptors in rat brain.,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
2192,chlorpromazine,621,Adenylate cyclase,Enzyme,D4A3N4|P21932|P26769|P26770|P40146|Q03343|Q04400|Q8CFM9,Adcy1|Adcy3|Adcy2|Adcy4|Adcy8|Adcy6|Adcy5,D4A3N4_RAT|ADCY3_RAT|ADCY2_RAT|ADCY4_RAT|ADCY8_RAT|ADCY6_RAT|ADCY5_RAT|Q8CFM9_RAT,6.93,,Ki,Inhibitory activity against Dopamine sensitive adenylate cyclase in rats,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:1309318
2195,chlorpromazine,621,Major prion protein,Unclassified,P04925,Prnp,PRIO_MOUSE,5.7,,EC50,Activity at mouse prion protein expressed in Escherichia coli,CHEMBL,=,,,,,,,Mus musculus,MGI:97769
2206,chlorprothixene,623,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.959,,Ki,,PDSP,,,,,,,Tclin,Homo sapiens,HGNC:1950
2217,chlortetracycline,624,Major prion protein,Surface antigen,P04156,PRNP,PRIO_HUMAN,,,,,WOMBAT-PK,,,,,,,Tchem,Homo sapiens,HGNC:9449
2234,chlorzoxazone,626,"Nitric oxide synthase, brain",Enzyme,P29475,NOS1,NOS1_HUMAN,4.3,,IC50,Inhibitory activity against Neuronal nitric oxide synthase,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:7872
2236,chlorzoxazone,626,"Nitric oxide synthase, brain",Enzyme,P29476,Nos1,NOS1_RAT,5.553999999999999,,IC50,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",DRUG MATRIX,=,,,,,,,Rattus norvegicus,RGD:3184
2238,chlorzoxazone,626,Calcium-activated potassium channel subunit alpha-1,Ion channel,Q12791,KCNMA1,KCMA1_HUMAN,4.523,,EC50,Chlorzoxazone-stimulated activity of BK(Ca) channels in neuroblastoma IMR-32 cells,SCIENTIFIC LITERATURE,=,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/12480161,https://pubmed.ncbi.nlm.nih.gov/12480161,OPENER,Tclin,Homo sapiens,HGNC:6284
2261,cianidanol,629,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,4.48,,IC50,Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,CHEMBL,=,,,,,,,Homo sapiens,HGNC:620
2264,cianidanol,629,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,4.48,,IC50,Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:620
2291,cilnidipine,642,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/9298526,https://pubmed.ncbi.nlm.nih.gov/9298526,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
2320,cinnarizine,654,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.218,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
2379,cisatracurium,661,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,8.0,,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201248,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
2388,citalopram,663,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.875,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
2459,clemastine,671,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.796,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
2486,clevidipine,674,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237132,BLOCKER,Tclin,Homo sapiens,HGNC:1390
2487,clevidipine,674,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237132,BLOCKER,Tclin,Homo sapiens,HGNC:1391
2488,clidinium,676,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL620,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
2494,clioquinol,681,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,4.0,,IC50,Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,CHEMBL,=,,,,,,,Homo sapiens,HGNC:620
2499,clodronic acid,690,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tchem,Homo sapiens,HGNC:9642
2531,clomifene,700,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.407,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
2565,clomipramine,701,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.657999999999999,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
2635,clotiapine,717,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,6.87,,Ki,In vitro binding affinity against Muscarinic acetylcholine receptors in rat brain.,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
2659,clotrimazole,719,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.7810000000000015,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
2745,clozapine,722,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.181000000000001,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
2768,clozapine,722,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.68,,Ki,Compound was tested for the binding affinity against rat cortical Muscarinic acetylcholine receptor M1 by radioligand [3H]pirenzepine binding assay.,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
2798,clozapine,722,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,7.6,,Ki,In vitro binding affinity against Muscarinic acetylcholine receptors in rat brain.,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
2804,clozapine,722,Adenylate cyclase,Enzyme,D4A3N4|P21932|P26769|P26770|P40146|Q03343|Q04400|Q8CFM9,Adcy1|Adcy3|Adcy2|Adcy4|Adcy8|Adcy6|Adcy5,D4A3N4_RAT|ADCY3_RAT|ADCY2_RAT|ADCY4_RAT|ADCY8_RAT|ADCY6_RAT|ADCY5_RAT|Q8CFM9_RAT,6.85,,IC50,Inhibition of dopamine-sensitive rat brain adenylyl cyclase activity assessed as cAMP level,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:1309318
2824,cocaine,723,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,4.21,,Ki,Displacement of [3H]pirenzepine from muscarinic acetylcholine receptor M1 of rat brain membrane,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
2852,colforsin daropate,729,Adenylate cyclase type 1,Enzyme,Q08828,ADCY1,ADCY1_HUMAN,7.39,,IC50,Inhibition of [125 I]6-IHPP-forskolin binding to adenylate cyclase 1,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:232
2896,cyamemazine,746,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.886,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
2908,cyclizine,749,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.787999999999999,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
2927,cyclobenzaprine,751,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.95,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
2988,cycrimine,763,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201227,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
3008,cyproheptadine,765,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.0,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
3031,cyproheptadine,765,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,8.4,,Ki,Displacement of [3H]- QNB binding at the muscarinic-cholinergic binding site of rat brain S1,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
3118,darifenacin,784,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.3,,Ki,GRAC: human M1 antagonist,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
3132,dasatinib,785,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,9.68,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,INHIBITOR,Tclin,Homo sapiens,HGNC:11283
3155,dasatinib,785,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,9.24,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,,,INHIBITOR,Tclin,Homo sapiens,HGNC:6735
3199,dasatinib,785,Proto-oncogene tyrosine-protein kinase Src,Kinase,P00523,SRC,SRC_CHICK,7.96,,Kd,Activity of wild type chicken c N-terminal His-tagged Src expressed in Escherichia coli BL21 (DE3),CHEMBL,=,,,,,,,Gallus gallus,ENSEMBL:ENSGALG00000003855
3275,decamethonium,789,Muscle-type nicotinic acetylcholine receptor,Ion channel,P02708|P07510|P11230|Q04844|Q07001,CHRNA1|CHRNG|CHRNB1|CHRNE|CHRND,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHE_HUMAN|ACHD_HUMAN,,,,Mechanism of Action; CHEMBL2362997; PROTEIN COMPLEX GROUP,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1190,PARTIAL AGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
3324,desipramine,812,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.76,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
3359,desloratadine,814,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.74,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
3425,dexetimide,831,Muscarinic acetylcholine receptor,GPCR,P12657|P32211|Q920H4|Q9ERZ3|Q9ERZ4,Chrm1|Chrm4|Chrm5|Chrm3|Chrm2,ACM1_MOUSE|ACM4_MOUSE|ACM5_MOUSE|ACM3_MOUSE|ACM2_MOUSE,8.48,,IC50,Ability (10 ug/kg) to inhibit binding of [125I]iododexetimide to muscarinic receptor in mice,CHEMBL,=,,,,,,,Mus musculus,MGI:88396
3438,dexfenfluramine,832,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.733,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
3481,dexniguldipine,837,Voltage-gated L-type calcium channel,Ion channel,P22002|P27732|Q02485,Cacna1c|Cacna1d|Cacna1s,CAC1C_RAT|CAC1D_RAT|CAC1S_RAT,7.22,,Ki,Inhibition of [3H]-isradipine binding to L-type [Ca2+] channel of rat brain membranes,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2245
3482,dexniguldipine,837,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/2547493,https://pubmed.ncbi.nlm.nih.gov/2547493,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
3627,dicloxacillin,866,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.96,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
3655,dicycloverine,868,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.079,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1123,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
3663,dicycloverine,868,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.61,,Ki,Displacement of [3H]pirenzepine from muscarinic acetylcholine receptor M1 in rat cortex homogenates,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
3690,diethylstilbestrol,875,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.437,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
3840,diltiazem,897,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,7.319,,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23,BLOCKER,Tclin,Homo sapiens,HGNC:1390
3842,diltiazem,897,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,Q13698,CACNA1S,CAC1S_HUMAN,6.42,,Ki,Displacement of [3H]diltiazem from L-type calcium channel of guinea pig striated muscle,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1397
3845,diltiazem,897,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P22002,Cacna1c,CAC1C_RAT,7.27,,IC50,Ability to inhibit [3H]nitrendipine binding to the L-type calcium channel receptor(CCR) in rat heart homogenate.,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2245
3846,diltiazem,897,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,P27732,Cacna1d,CAC1D_RAT,7.34,,IC50,"Inhibition of [3H]nitrendipine binding to L-type [Ca2+] channel in rat cortex homogenate, activity expressed as pIC50",CHEMBL,=,,,,,,,Rattus norvegicus,RGD:70973
3849,diltiazem,897,Voltage-gated L-type calcium channel,Ion channel,P22002|P27732|Q02485,Cacna1c|Cacna1d|Cacna1s,CAC1C_RAT|CAC1D_RAT|CAC1S_RAT,7.8,,Ki,Inhibitory constant against calcium channel receptors (CCRs),CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2245
3852,diltiazem,897,Voltage-dependent L-type calcium channel subunit alpha-1F,Ion channel,Q9JIS7,Cacna1f,CAC1F_MOUSE,4.0,,IC50,,IUPHAR,=,,,,,BLOCKER,,Mus musculus,MGI:1859639
3862,dimenhydrinate,901,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.962999999999999,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
3872,dimetindene,903,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.58,,Ki,,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
3877,dimethyltubocurarinium,908,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.745,,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1259,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
3923,diphemanil,915,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201340,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
3932,diphenhydramine,916,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.0,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
3946,diphenylpyraline,920,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.699,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
3980,disopyramide,926,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1950
4164,dopamine,947,Adenylate cyclase,Enzyme,D4A3N4|P21932|P26769|P26770|P40146|Q03343|Q04400|Q8CFM9,Adcy1|Adcy3|Adcy2|Adcy4|Adcy8|Adcy6|Adcy5,D4A3N4_RAT|ADCY3_RAT|ADCY2_RAT|ADCY4_RAT|ADCY8_RAT|ADCY6_RAT|ADCY5_RAT|Q8CFM9_RAT,5.46,,EC50,Tested for ability to stimulate dopamine sensitive adenylate cyclase in rat caudate homogenate,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:1309318
4208,dosulepin,951,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.744,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
4251,doxepin,956,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.42,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
4268,doxorubicin,960,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.433,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
4329,drotaverine,969,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1390
4330,droxidopa,971,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.1,,Ki,,IUPHAR,=,,,,,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
4332,droxidopa,971,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.1,,Ki,,IUPHAR,=,,,,,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
4375,ebastine,977,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.96,,IC50,Compound is evaluated for in vitro receptor binding affinity against Muscarinic acetylcholine receptor M1,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
4418,econazole,983,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.197,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
4474,edetic acid,987,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,5.11,,IC50,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,CHEMBL,=,,,,,,,Homo sapiens,HGNC:620
4491,efonidipine,992,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/17276408,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
4523,endralazine,1008,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1390
4664,ergotamine,1043,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.064,,Ki,,PDSP,,,,,,,Tclin,Homo sapiens,HGNC:1950
4696,erlotinib,1045,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.15,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
4708,erlotinib,1045,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,5.13,,IC50,Inhibition of FAK (unknown origin) assembly preincubated with enzyme followed by GTP addition measured after 20 mins by spectrophotometric analysis,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:9611
4719,erlotinib,1045,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.28,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:6735
4754,erlotinib,1045,Proto-oncogene tyrosine-protein kinase Src,Kinase,P00523,SRC,SRC_CHICK,6.0,,IC50,Inhibition of chicken cSrc single mutant expressed in Escherichia coli,CHEMBL,=,,,,,,,Gallus gallus,ENSEMBL:ENSGALG00000003855
4814,escitalopram,1053,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.9060000000000015,,Ki,,PDSP,,,,,,,Tclin,Homo sapiens,HGNC:1950
4832,estradiol,1057,Calcium-activated potassium channel subunit alpha-1,Ion channel,Q12791,KCNMA1,KCMA1_HUMAN,5.6,,EC50,,IUPHAR,=,,,,,ACTIVATOR,Tclin,Homo sapiens,HGNC:6284
4864,estramustine phosphate,1066,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,4.2,,IC50,Inhibition of recombinant PTP1B,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:9642
4935,profenamine,1086,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1206,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
4941,profenamine,1086,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.51,,Ki,Displacement of [<sup<3</sup>H]QNB binding in rat forebrain brain homogenate.,IUPHAR,=,,,,,ANTAGONIST,,Rattus norvegicus,RGD:2342
5109,felodipine,1142,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1480,BLOCKER,Tclin,Homo sapiens,HGNC:1390
5110,felodipine,1142,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1480,BLOCKER,Tclin,Homo sapiens,HGNC:1391
5137,fenfluramine,1150,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.016,,Ki,,PDSP,,,,,,,Tclin,Homo sapiens,HGNC:1950
5311,flunarizine,1200,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.151,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
5379,fluoxetine,1209,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.0470000000000015,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
5440,fluphenazine,1212,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.0,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
5475,fluphenazine,1212,Adenylate cyclase,Enzyme,D4A3N4|P21932|P26769|P26770|P40146|Q03343|Q04400|Q8CFM9,Adcy1|Adcy3|Adcy2|Adcy4|Adcy8|Adcy6|Adcy5,D4A3N4_RAT|ADCY3_RAT|ADCY2_RAT|ADCY4_RAT|ADCY8_RAT|ADCY6_RAT|ADCY5_RAT|Q8CFM9_RAT,7.1,,IC50,The compound was tested for adenylate cyclase activity in rat corpus striatum,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:1309318
5492,fluphenazine enanthate,1214,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.961,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
5670,gallamine,1273,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.07,,Ki,Competitive inhibition of EGFP-fused human M1 receptor N-terminal truncated at 17 residues expressed in HEK293 cells after 4 hrs by FRET assay in presence of para-LRB-AC42,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
5675,gallamine,1273,Acetylcholine receptor subunit alpha,Ion channel,P02708,CHRNA1,ACHA_HUMAN,6.0,,IC50,,IUPHAR,~,,,,,BLOCKER,Tclin,Homo sapiens,HGNC:1955
5714,gefitinib,1282,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.0,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:6735
5775,gefitinib,1282,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.42,,Kd,,SCIENTIFIC LITERATURE,,,,https://pubmed.ncbi.nlm.nih.gov/22037378,,,Tclin,Homo sapiens,HGNC:11283
5954,haloperidol,1353,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.8,,Ki,Binding affinity to human cloned muscarinic M1 receptor,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
5974,haloperidol,1353,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,5.74,,Ki,Compound was tested for the binding affinity against rat cortical Muscarinic acetylcholine receptor M1 by Radio ligand [3H]pirenzepine binding assay.,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
5997,haloperidol,1353,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,5.13,,Ki,In vitro binding affinity against Muscarinic acetylcholine receptors in rat brain.,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
6005,haloperidol,1353,Adenylate cyclase,Enzyme,D4A3N4|P21932|P26769|P26770|P40146|Q03343|Q04400|Q8CFM9,Adcy1|Adcy3|Adcy2|Adcy4|Adcy8|Adcy6|Adcy5,D4A3N4_RAT|ADCY3_RAT|ADCY2_RAT|ADCY4_RAT|ADCY8_RAT|ADCY6_RAT|ADCY5_RAT|Q8CFM9_RAT,5.64,,IC50,Inhibition of dopamine-sensitive rat brain adenylyl cyclase activity assessed as cAMP level,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:1309318
6100,hexocyclium,1371,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,UNKNOWN,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201325,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
6105,hexocyclium,1371,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.6,,Ki,,IUPHAR,=,,,,,ANTAGONIST,,Rattus norvegicus,RGD:2342
6125,homatropine,1379,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.495,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
6132,hydralazine,1384,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1390
6147,hydrochlorothiazide,1385,Calcium-activated potassium channel subunit alpha-1,Ion channel,Q12791,KCNMA1,KCMA1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:6284
6176,hydroxychloroquine,1395,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,4.81,,Ki,Activity of compound against Muscarinic acetylcholine receptor M1 (CHRM1) by displacement of 3H-QNB,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
6204,hyoscyamine,1402,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.0,,Ki,,WOMBAT-PK,=,1.0,KEGG DRUG,,http://www.kegg.jp/entry/D00147,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
6308,imatinib,1423,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,4.51,,Ki,Inhibition of recombinant human c-Src,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
6326,imatinib,1423,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.05,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:6735
6348,imatinib,1423,Proto-oncogene tyrosine-protein kinase Src,Kinase,P00523,SRC,SRC_CHICK,5.56,,IC50,Inhibition of chicken wild-type cSRC (251 to 533)-mediated phosphorylation of biotinylated poly-Glu-Tyr expressed in Escherichia coli BL21(DE3) preincubated for 30 to 60 mins prior to substrate addition by TR-FRET assay,CHEMBL,=,,,,,,,Gallus gallus,ENSEMBL:ENSGALG00000003855
6385,imipramine,1427,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.3770000000000024,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
6392,imipramine,1427,Major prion protein,Surface antigen,P04156,PRNP,PRIO_HUMAN,5.0,,EC50,Half maximal inhibition of Prion protein PrPsc formation was assayed in ScN2a cells,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:9449
6408,imipramine,1427,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,7.19,,Ki,Binding affinity against Muscarinic acetylcholine receptor was determined in homogenized rat cortex tissue using [3H]N-methylscopolamine as radioligand,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
6518,ipratropium,1475,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.31,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
6524,ipratropium,1475,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,9.54,,Ki,Displacement of [3H]-NMS from Sprague-Dawley rat muscarinic M1 receptor in cortex membrane,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
6626,isopropamide,1500,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201232,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
6649,isradipine,1511,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,8.8,,IC50,,IUPHAR,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL399539,GATING INHIBITOR,Tclin,Homo sapiens,HGNC:1390
6650,isradipine,1511,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,9.3,,IC50,Recombinant Ca<sub>v</sub>1.3 calcium channel complexes expressed in tsA201-cells,IUPHAR,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL399539,GATING INHIBITOR,Tclin,Homo sapiens,HGNC:1391
6653,isradipine,1511,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,P27732,Cacna1d,CAC1D_RAT,6.66,,IC50,Antagonist activity at rat voltage-dependent L-type calcium channel Cav1.3alpha-1D expressed in HEK293 cells by FLIPR assay,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:70973
6654,isradipine,1511,Voltage-dependent L-type calcium channel subunit alpha-1F,Ion channel,Q9JIS7,Cacna1f,CAC1F_MOUSE,6.7,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,,Mus musculus,MGI:1859639
6655,isradipine,1511,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q01815,Cacna1c,CAC1C_MOUSE,7.5,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,,Mus musculus,MGI:103013
6777,ketorolac,1529,Serine/threonine-protein kinase PAK 1,Kinase,Q13153,PAK1,PAK1_HUMAN,4.44,,IC50,Inhibition of PAK1 in human A549 cells using myelin basic protein as substrate preincubated for 24 hrs followed by PAK1 immunoprecipation and substrate addition measured after 60 mins by ATP-Glo kinase assay,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:8590
6791,ketotifen,1530,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.016,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
6821,lacidipine,1532,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/17276408,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
6923,levamisole,1561,Acetylcholine receptor subunit alpha-type unc-63,Ion channel,Q9N587,unc-63,ACH6_CAEEL,,,,,WOMBAT-PK,,,,,,,,Caenorhabditis elegans,WormBase:WBGene00006797
6987,levosimendan,1576,"Troponin C, slow skeletal and cardiac muscles",Cytosolic other,P63316,TNNC1,TNNC1_HUMAN,3.155,,Kd,affinity for the binding of levosimendan to cNTnC-Ca2+-cTnI-(144-163) complex,SCIENTIFIC LITERATURE,=,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/18570382,https://pubmed.ncbi.nlm.nih.gov/18570382,OPENER,Tclin,Homo sapiens,HGNC:11943
7005,lidocaine,1579,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,4.955,,IC50,,WOMBAT-PK,=,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
7075,lofepramine,1592,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.1739999999999995,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
7181,lovastatin,1612,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,4.59,,IC50,Inhibition of recombinant HDAC2 (unknown origin) after 10 mins by fluorimetric analysis,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:4853
7207,loxapine,1613,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.26,,IC50,Inhibition of binding of 1.0 nM [3H]pirenzepine to cloned human Muscarinic acetylcholine receptor M1 expressed in membranes from CHO-K1 cells,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
7296,manidipine,1631,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/8287905,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
7313,maprotiline,1634,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.845,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
7374,mebhydrolin,1643,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.745,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
7384,mecamylamine,1646,Acetylcholine receptor subunit alpha,Ion channel,P02708,CHRNA1,ACHA_HUMAN,5.82,,IC50,,IUPHAR,~,,,,,BLOCKER,Tclin,Homo sapiens,HGNC:1955
7505,menadione,1683,Dual specificity phosphatase Cdc25A,Enzyme,P30304,CDC25A,MPIP1_HUMAN,5.16,,IC50,Inhibition of recombinant Cdc25A (unknown origin) using OMFP as substrate measured every 30 sec for 10 mins by fluorometric assay,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:1725
7508,menadione,1683,M-phase inducer phosphatase 1,Enzyme,P30304,CDC25A,MPIP1_HUMAN,5.16,,IC50,Inhibition of recombinant Cdc25A (unknown origin) using OMFP as substrate measured every 30 sec for 10 mins by fluorometric assay,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:1725
7522,pecazine,1688,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.721,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
7533,mepenzolate,1689,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL524004,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
7572,mequitazine,1707,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.252,,Ki,,PDSP,,,,,,,Tclin,Homo sapiens,HGNC:1950
7614,mesoridazine,1712,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.0,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
7671,methacholine,1726,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.638,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
7676,methacholine,1726,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,6.4,,EC50,,IUPHAR,=,,,,,AGONIST,,Rattus norvegicus,RGD:2342
7712,methapyrilene,1738,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.939,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
7815,methscopolamine,1757,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.9,,Ki,,IUPHAR,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201268,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
7837,methylthioninium chloride,1763,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,6.26,,IC50,,CHEMBL,=,,,,,,,Homo sapiens,HGNC:620
7901,methysergide,1775,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.263,,Ki,,PDSP,,,,,,,Tclin,Homo sapiens,HGNC:1950
7931,metixene,1780,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201342,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
7941,metoclopramide,1782,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1950
8023,mezlocillin,1795,Serum albumin,Secreted,P02768,ALB,ALBU_HUMAN,4.18,,Ki,,WOMBAT-PK,=,,,,,,Tchem,Homo sapiens,HGNC:399
8045,mianserin,1796,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.465,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
8090,mibefradil,1797,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,4.9,,IC50,,IUPHAR,=,,,,,BLOCKER,Tclin,Homo sapiens,HGNC:1390
8129,miconazole,1800,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.02,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
8260,miltefosine,1810,Dual specificity phosphatase Cdc25A,Enzyme,P30304,CDC25A,MPIP1_HUMAN,4.6,,IC50,Inhibition of Cell division cycle 25 (Cdc25) phosphatase,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:1725
8266,minaprine,1812,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,4.77,,Ki,Binding affinity towards muscarinic M1 receptor,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
8268,minaprine,1812,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,4.77,,IC50,Displacement of [3H]pirenzepine from cerebral Muscarinic acetylcholine receptor M1,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
8287,mirtazapine,1816,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1950
8317,mitoxantrone,1821,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.744,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
8341,mivacurium,1822,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL984,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
8396,montelukast,1836,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.712999999999999,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
8691,nicotinamide,1906,NAD-dependent protein deacetylase sirtuin-2,Enzyme,Q8IXJ6,SIRT2,SIR2_HUMAN,5.92,,IC50,Inhibition of recombinant SIRT2 using ZMAL substrate after 4 hrs by homogeneous fluorescence assay,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:10886
8713,nicardipine,1909,Voltage-gated L-type calcium channel,Ion channel,P22002|P27732|Q02485,Cacna1c|Cacna1d|Cacna1s,CAC1C_RAT|CAC1D_RAT|CAC1S_RAT,9.08,,Ki,Inhibition of [3H]nitrendipine binding to L-type calcium channel from rat brain cortex homogenate,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2245
8714,nicardipine,1909,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1484,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
8720,niclosamide,1912,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.0,,IC50,Inhibition of Src kinase,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
8724,niclosamide,1912,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,4.62,,IC50,Inhibition of LYN after 60 mins by radiometric assay,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:6735
8753,nicotine,1920,Acetylcholine receptor subunit beta-like 2,Ion channel,P25162,nAChRbeta2,ACH4_DROME,5.57,,Ki,Binding affinity to Drosophila brain nicotinic acetylcholine receptor assessed as [3H]IMI binding by radioligand binding assay,CHEMBL,=,,,,,,,Drosophila melanogaster,FlyBase:FBgn0004118
8769,nicotine,1920,Acetylcholine receptor; alpha1/beta1/delta/gamma,Ion channel,P02708|P07510|P11230|Q07001,CHRNA1|CHRNG|CHRNB1|CHRND,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHD_HUMAN,5.83,,Ki,Binding affinity to alpha-1-beta-gamma-delta nicotinic receptor,CHEMBL,=,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
8773,nicotine,1920,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,4.55,,IC50,Inhibitory concentration required for in vitro binding affinity to cholinergic central muscarinic receptor on rat brain cortex by using [3H]OXO-M,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
8774,nicotine,1920,Acetylcholine receptor subunit alpha,Ion channel,P02708,CHRNA1,ACHA_HUMAN,4.68,,IC50,Inhibition of [3H]alpha-BGT binding to alpha1 nicotinic acetylcholine receptor in Homo sapiens (human) TE671 cells co-expressing gammaalpha1deltabeta1 nicotinic acetylcholine receptor subunits,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1955
8790,nifedipine,1922,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,7.7,,IC50,Recombinant Cav1.3 calcium channel complexes expressed in tsA-cells,IUPHAR,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,GATING INHIBITOR,Tclin,Homo sapiens,HGNC:1391
8795,nifedipine,1922,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,Q13698,CACNA1S,CAC1S_HUMAN,6.3,,IC50,,IUPHAR,=,,,,,INHIBITOR,Tclin,Homo sapiens,HGNC:1397
8803,nifedipine,1922,Voltage-dependent L-type calcium channel subunit alpha-1F,Ion channel,O60840,CACNA1F,CAC1F_HUMAN,6.0,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,Tclin,Homo sapiens,HGNC:1393
8810,nifedipine,1922,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P22002,Cacna1c,CAC1C_RAT,8.46,,Ki,"Inhibition of [3H](+)-PN200-110 binding to L-type calcium channel 1,4-DHP binding site of rat ventricular myocytes",CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2245
8811,nifedipine,1922,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,P27732,Cacna1d,CAC1D_RAT,8.92,,Ki,Binding affinity for L-type [Ca2+] channels was measured through displacement of [3H]nitrendipine on rat cortex homogenates.,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:70973
8816,nifedipine,1922,Voltage-gated L-type calcium channel,Ion channel,P22002|P27732|Q02485,Cacna1c|Cacna1d|Cacna1s,CAC1C_RAT|CAC1D_RAT|CAC1S_RAT,8.33,,Ki,Inhibition of [3H]nitrendipine binding to L-type calcium channel from rat brain cortex homogenate,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2245
8823,nifedipine,1922,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,9.4,,Kd,Displacement of [3H]nitrendipine from dihydropyridine receptor of guinea pig myocardial membranes,CHEMBL,=,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/17276408,BLOCKER,Tclin,Homo sapiens,HGNC:1390
8850,nilotinib,1932,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.72,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
8871,nilotinib,1932,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,7.0,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:6735
8915,nilvadipine,1934,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1390
8916,nilvadipine,1934,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1391
8917,nilvadipine,1934,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/7898101,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
8936,nimodipine,1937,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,UNKNOWN,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1428,BLOCKER,Tclin,Homo sapiens,HGNC:1390
8937,nimodipine,1937,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,,,,,UNKNOWN,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1428,BLOCKER,Tclin,Homo sapiens,HGNC:1391
8940,nimodipine,1937,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,Q13698,CACNA1S,CAC1S_HUMAN,6.0,,IC50,,IUPHAR,~,,,,,GATING INHIBITOR,Tclin,Homo sapiens,HGNC:1397
8943,nimodipine,1937,Voltage-dependent L-type calcium channel subunit alpha-1F,Ion channel,O60840,CACNA1F,CAC1F_HUMAN,6.0,,IC50,,IUPHAR,~,,,,,GATING INHIBITOR,Tclin,Homo sapiens,HGNC:1393
8946,nimodipine,1937,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P22002,Cacna1c,CAC1C_RAT,6.8,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,,Rattus norvegicus,RGD:2245
8947,nimodipine,1937,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,P27732,Cacna1d,CAC1D_RAT,6.6,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,,Rattus norvegicus,RGD:70973
8952,nisoldipine,1942,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,7.1,,IC50,,IUPHAR,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1726,GATING INHIBITOR,Tclin,Homo sapiens,HGNC:1390
8953,nisoldipine,1942,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,,,,,UNKNOWN,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1726,BLOCKER,Tclin,Homo sapiens,HGNC:1391
8957,nisoldipine,1942,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q01815,Cacna1c,CAC1C_MOUSE,8.0,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,,Mus musculus,MGI:103013
8958,nisoldipine,1942,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q99246,Cacna1d,CAC1D_MOUSE,7.0,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,,Mus musculus,MGI:88293
8973,nitrendipine,1947,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,8.4,,IC50,Recombinant Cav1.3 calcium channel complexes expressed in tsA-cells,IUPHAR,=,1.0,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2334,GATING INHIBITOR,Tclin,Homo sapiens,HGNC:1391
8977,nitrendipine,1947,Voltage-dependent L-type calcium channel subunit alpha-1F,Ion channel,O60840,CACNA1F,CAC1F_HUMAN,6.0,,IC50,,IUPHAR,~,,,,,GATING INHIBITOR,Tclin,Homo sapiens,HGNC:1393
8980,nitrendipine,1947,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P22002,Cacna1c,CAC1C_RAT,6.0,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,,Rattus norvegicus,RGD:2245
8981,nitrendipine,1947,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,Q02485,Cacna1s,CAC1S_RAT,6.0,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,,Rattus norvegicus,RGD:70983
8984,nitrendipine,1947,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,9.6,,Ki,Inhibition of [3H]nitrendipine binding to L-type calcium channel dihydropyridine site of porcine cardiac sarcolemma membrane vesicles,CHEMBL,=,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/17276408,BLOCKER,Tclin,Homo sapiens,HGNC:1390
9092,nortriptyline,1971,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.398,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
9109,nortriptyline,1971,ATP-sensitive inward rectifier potassium channel 10,Ion channel,P78508,KCNJ10,KCJ10_HUMAN,4.796,,IC50,inhibition at +30 mV,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/17071817,,BLOCKER,Tbio,Homo sapiens,HGNC:6256
9140,ofloxacin,1981,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,4.41,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
9167,olanzapine,1982,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.506,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
9188,olanzapine,1982,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,7.66,,Ki,Half-maximal inhibition of [3H]QNB binding to Muscarinic acetylcholine receptor M1 in rat frontal cortex homogenate,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
9216,omapatrilat,1989,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,6.7,,IC50,Inhibition of APP (unknown origin),CHEMBL,=,,,,,,,Homo sapiens,HGNC:620
9217,omapatrilat,1989,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,6.7,,IC50,Inhibition of APP (unknown origin),CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:620
9237,ondansetron,1992,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,5.0,,Ki,The binding affinity was measured on muscarine M1 receptor using [3H]- pirenzepine as radioligand.,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
9286,orphenadrine,1999,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.39,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
9341,oxatomide,2014,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.13,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
9346,oxyphencyclimine,2026,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200891,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
9363,oxybutynin,2028,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.23,,Ki,Binding affinity for rat cortex muscarinic acetylcholine receptor M1 using [3H]pirenzepine,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
9365,oxybutynin,2028,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.0,,Ki,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M1 receptor expressed in Sf9 cells,CHEMBL,=,1.0,DRUG LABEL,,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000532/WC500040171.pdf,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
9426,oxyphenonium,2039,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200906,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
9474,aminosalicylic acid,2050,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,2.92,,Kd,Dissociation constant for Protein-tyrosine phosphatase 1B,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:9642
9476,pancuronium,2052,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,8.201,,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL185073,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
9478,pancuronium,2052,Acetylcholine receptor; alpha1/beta1/delta/gamma,Ion channel,P02708|P07510|P11230|Q07001,CHRNA1|CHRNG|CHRNB1|CHRND,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.09,,IC50,GRAC: human AChR-alpha1 commonly used antagonist,CHEMBL,=,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
9525,paroxetine,2068,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.456,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
9701,perhexiline,2106,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.185,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
9772,phencyclidine,2121,Muscarinic acetylcholine receptor,GPCR,P12657|P32211|Q920H4|Q9ERZ3|Q9ERZ4,Chrm1|Chrm4|Chrm5|Chrm3|Chrm2,ACM1_MOUSE|ACM4_MOUSE|ACM5_MOUSE|ACM3_MOUSE|ACM2_MOUSE,5.04,,Kd,Dissociation constant towards Muscarinic acetylcholine receptor was determined by using [3H]4NMPB as radioligand,CHEMBL,=,,,,,,,Mus musculus,MGI:88396
9880,phenylpropanolamine,2149,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.171,,Ki,,PDSP,,,,,,,Tclin,Homo sapiens,HGNC:1950
9914,physostigmine,2159,Muscarinic acetylcholine receptor M1,GPCR,P12657,Chrm1,ACM1_MOUSE,4.43,,IC50,Binding affinity against mouse muscarinic acetylcholine receptor M1 using cerebral cortex and [3H]pirenzepine,CHEMBL,=,,,,,,,Mus musculus,MGI:88396
9931,pilocarpine,2166,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,5.51,,Ki,"Compound was evaluated for its affinity towards Muscarinic acetylcholine receptor M1, using [3H]- pirenzepine, a radioligand displacement assay in rat hippocampal membranes",CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
9932,pilocarpine,2166,Muscarinic acetylcholine receptor M1,GPCR,P12657,Chrm1,ACM1_MOUSE,5.16,,EC50,Tested against Muscarinic acetylcholine receptor M1 expressed in A9 L cell line,CHEMBL,=,,,,,,,Mus musculus,MGI:88396
9933,pilocarpine,2166,Muscarinic acetylcholine receptor DM1,GPCR,P16395,mAChR-A,ACM1_DROME,5.55,,Ki,Displacement of [3H]AF-DX 384 from Drosophila melanogaster mAChR by scintillation counting,CHEMBL,=,,,,,,,Drosophila melanogaster,FlyBase:FBgn0000037
9934,pilocarpine,2166,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,7.08,,Ki,Inhibition of [3H]OXO-M binding against muscarinic acetylcholine receptor in rat brain membranes,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
9935,pilocarpine,2166,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.02,,EC50,calcium response in CHO cells,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/24558448,,AGONIST,Tclin,Homo sapiens,HGNC:1950
9993,pinacidil,2173,Calcium-activated potassium channel subunit alpha-1,Ion channel,Q12791,KCNMA1,KCMA1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:6284
10065,pipecuronium,2183,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201206,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
10076,pirenzepine,2200,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.68,,Ki,,WOMBAT-PK,=,1.0,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=328,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
10083,pirenzepine,2200,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.28,,Ki,Displacement of [3H]pirenzepine from muscarinic acetylcholine receptor M1 in rat cortex homogenates,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
10088,pirenzepine,2200,Muscarinic acetylcholine receptor DM1,GPCR,P16395,mAChR-A,ACM1_DROME,6.41,,Ki,Displacement of [3H]AF-DX 384 from Drosophila melanogaster mAChR by scintillation counting,CHEMBL,=,,,,,,,Drosophila melanogaster,FlyBase:FBgn0000037
10089,pirenzepine,2200,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,7.22,,Ki,Binding affinity against Muscarinic acetylcholine receptor was determined in homogenized rat cortex tissue using [3H]N-methylscopolamine as radioligand,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
10090,pirenzepine,2200,Muscarinic acetylcholine receptor,GPCR,P12657|P32211|Q920H4|Q9ERZ3|Q9ERZ4,Chrm1|Chrm4|Chrm5|Chrm3|Chrm2,ACM1_MOUSE|ACM4_MOUSE|ACM5_MOUSE|ACM3_MOUSE|ACM2_MOUSE,6.12,,IC50,Ability (10 ug/kg) to inhibit binding of [125I]iododexetimide to muscarinic receptor in mice,CHEMBL,=,,,,,,,Mus musculus,MGI:88396
10127,pizotifen,2220,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.7,,Ki,Binding affinity to muscarinic M1 receptor (unknown origin),CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
10210,prenylamine,2261,Voltage-gated L-type calcium channel,Ion channel,P22002|P27732|Q02485,Cacna1c|Cacna1d|Cacna1s,CAC1C_RAT|CAC1D_RAT|CAC1S_RAT,6.68,,Kd,Inhibition of [3H]nitrendipine binding to calcium channel of rat brain membranes.,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2245
10212,pridinol,2263,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.796,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
10262,procaine,2271,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,4.342,,IC50,,WOMBAT-PK,=,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
10282,prochlorperazine,2274,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.6129999999999995,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
10301,procyclidine,2276,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.337,,Ki,,PDSP,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86715,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
10361,promazine,2284,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.825,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
10370,promazine,2284,Major prion protein,Surface antigen,P04156,PRNP,PRIO_HUMAN,5.3,,EC50,Half maximal inhibition of Prion protein PrPsc formation was assayed in ScN2a cells,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:9449
10402,promethazine,2286,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.479,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
10412,promethazine,2286,Major prion protein,Surface antigen,P04156,PRNP,PRIO_HUMAN,5.1,,EC50,Half maximal inhibition of Prion protein PrPsc formation was assayed in ScN2a cells,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:9449
10456,propantheline,2293,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.7,,Ki,,IUPHAR,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1180725,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
10470,propiomazine,2298,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1950
10506,propranolol,2303,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,4.319,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1390
10549,protriptyline,2320,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.7,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
10583,pyrimethamine,2332,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.721,,Ki,,PDSP,,,,,,,Tclin,Homo sapiens,HGNC:1950
10632,quetiapine,2337,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.25,,Ki,Binding affinity towards human M1 receptor.,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
10663,mepacrine,2338,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.445,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
10672,mepacrine,2338,Major prion protein,Surface antigen,P04156,PRNP,PRIO_HUMAN,6.52,,EC50,Half maximal inhibition of Prion protein PrPsc formation was assayed in ScN2a cells,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:9449
10943,risperidone,2389,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.55,,Ki,Binding affinity to human cloned muscarinic M1 receptor,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
11023,rocuronium,2396,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.77,,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200648,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
11024,rocuronium,2396,Acetylcholine receptor; alpha1/beta1/delta/gamma,Ion channel,P02708|P07510|P11230|Q07001,CHRNA1|CHRNG|CHRNB1|CHRND,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.09,,IC50,GRAC: human AChR-alpha1 commonly used antagonist,CHEMBL,=,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
11161,scopolamine,2424,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.0,,Ki,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2251240,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
11167,scopolamine,2424,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,9.28,,Ki,Binding affinity towards rat Muscarinic acetylcholine receptor M1 was determined,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
11170,scopolamine,2424,Muscarinic acetylcholine receptor DM1,GPCR,P16395,mAChR-A,ACM1_DROME,9.15,,Ki,Displacement of [3H]AF-DX 384 from Drosophila melanogaster mAChR by scintillation counting,CHEMBL,=,,,,,,,Drosophila melanogaster,FlyBase:FBgn0000037
11171,scopolamine,2424,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,10.1,,Ki,Inhibition of [3H]pirenzepine binding to muscarinic receptor in rat cortical homogenates,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
11231,sertraline,2436,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.127999999999999,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
11360,solifenacin,2457,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.2,,IC50,Displacement of [3H]NMS from human muscarinic M1 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
11366,solifenacin,2457,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.0,,Ki,Binding affinity for rat cortex muscarinic acetylcholine receptor M1 using [3H]pirenzepine,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
11381,sorafenib,2459,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.41,,IC50,Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
11404,sorafenib,2459,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,5.52,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:6735
11549,spiperone,2470,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,4.3,,Ki,Displacement of [3H]- QNB binding at the muscarinic-cholinergic binding site of rat brain S1,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
11586,strychnine,2484,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.0,,Kd,,IUPHAR,=,,,,,ALLOSTERIC MODULATOR,Tclin,Homo sapiens,HGNC:1950
11598,suxamethonium,2489,Muscle-type nicotinic acetylcholine receptor,Ion channel,P02708|P07510|P11230|Q04844|Q07001,CHRNA1|CHRNG|CHRNB1|CHRNE|CHRND,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHE_HUMAN|ACHD_HUMAN,,,,Mechanism of Action; CHEMBL2362997; PROTEIN COMPLEX GROUP,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL703,AGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
11639,sulconazole,2495,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.053,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
11782,suloctidil,2536,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.965,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
11880,sunitinib,2544,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.68,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
11897,sunitinib,2544,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,6.36,,Kd,Binding constant for PTK2 kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:9611
11911,sunitinib,2544,Serine/threonine-protein kinase MARK2,Kinase,Q7KZI7,MARK2,MARK2_HUMAN,6.51,,Kd,Binding constant for MARK2 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:3332
11913,sunitinib,2544,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.57,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:6735
11992,sunitinib,2544,Proto-oncogene tyrosine-protein kinase Src,Kinase,P00523,SRC,SRC_CHICK,6.26,,IC50,Inhibition of chicken wild-type cSRC (251 to 533)-mediated phosphorylation of biotinylated poly-Glu-Tyr expressed in Escherichia coli BL21(DE3) preincubated for 30 to 60 mins prior to substrate addition by TR-FRET assay,CHEMBL,=,,,,,,,Gallus gallus,ENSEMBL:ENSGALG00000003855
11993,sunitinib,2544,Serine/threonine-protein kinase PAK 3,Kinase,O75914,PAK3,PAK3_HUMAN,7.8,,Kd,Binding constant for full-length PAK3,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:8592
12038,sunitinib,2544,Serine/threonine-protein kinase PAK 7,Kinase,Q9P286,PAK5,PAK5_HUMAN,6.19,,Kd,Binding constant for PAK7/PAK5 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:15916
12065,sunitinib,2544,Serine/threonine-protein kinase PAK 4,Kinase,O96013,PAK4,PAK4_HUMAN,5.64,,Kd,Binding constant for PAK4 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:16059
12165,tacrine,2551,Muscarinic acetylcholine receptor M1,GPCR,P12657,Chrm1,ACM1_MOUSE,5.7,,IC50,Binding affinity against mouse Muscarinic acetylcholine receptor M1 using cerebral cortex and [3H]pirenzepine,CHEMBL,=,,,,,,,Mus musculus,MGI:88396
12175,tacrine,2551,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,5.23,,IC50,Inhibition of [3H]quinuclidinyl benzilate (QNB) binding from rat forebrain membranes in the presence of Zn,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
12176,tacrine,2551,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,7.91,,IC50,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,CHEMBL,=,,,,,,,Homo sapiens,HGNC:620
12244,tamoxifen,2561,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.1670000000000025,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
12390,terconazole,2599,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.862,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
12420,terfenadine,2600,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.54,,IC50,Compound is evaluated for in vitro receptor binding affinity against Muscarinic acetylcholine receptor M1,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
12497,sapropterin,2612,"Nitric oxide synthase, brain",Enzyme,P29475,NOS1,NOS1_HUMAN,5.95,,Kd,Activity of tetrahydrobiopterin free nNOS,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:7872
12554,thiethylperazine,2630,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1950
12598,thioridazine,2637,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.568999999999999,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
12629,thioridazine,2637,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,8.7,,IC50,Displacement of [3H]quinuclidinyl benzilate (QNB) from Muscarinic acetylcholine receptor in rat brain,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
12652,thiothixene,2639,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.585,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
12712,tiludronic acid,2666,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tchem,Homo sapiens,HGNC:9642
12722,tiotropium bromide,2677,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,11.0,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
12728,tiotropium bromide,2677,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,9.8,,Ki,Displacement of [3H]-NMS from Sprague-Dawley rat muscarinic M1 receptor in cortex membrane,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
12730,tiquizium,2678,Muscarinic acetylcholine receptor,GPCR,F1PT23,CHRM1,F1PT23_CANFA,8.7,,Ki,radioligand ([3H]QNB) displacement assay,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/8839659,,,,Canis familiaris,ENSEMBL:ENSCAFG00000015467
12795,tolterodine,2705,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.85,,Ki,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M1 receptor expressed in CHO cells,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
12801,tolterodine,2705,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.85,,Ki,Displacement of [3H]NMS from muscarinic receptor M1 in Sprague-Dawley rat brain homogenates after 60 mins by liquid scintillation counting method,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
13008,tridihexethyl,2737,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201354,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
13072,trihexyphenidyl,2745,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.89,,IC50,Evaluated for its binding affinity at human muscarinic receptor m1 by displacement of [3H]NMS binding using membranes in transfected chinese hamster ovarian cell,CHEMBL,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1092,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
13151,troglitazone,2767,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,4.26,,IC50,Inhibition of PTP1B,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:9642
13164,tropicamide,2774,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.1670000000000025,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
13187,tropisetron,2775,Acetylcholine receptor; alpha1/beta1/delta/gamma,Ion channel,P02708|P07510|P11230|Q07001,CHRNA1|CHRNG|CHRNB1|CHRND,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHD_HUMAN,4.57,,Ki,In vitro Binding affinity towards alpha-1-beta-1-gamma-delta nAChR was determined,CHEMBL,=,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
13192,trospium,2776,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1950
13219,tubocurarine,2781,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.62,,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL339427,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
13224,tubocurarine,2781,Acetylcholine receptor; alpha1/beta1/delta/gamma,Ion channel,P02708|P07510|P11230|Q07001,CHRNA1|CHRNG|CHRNB1|CHRND,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.09,,IC50,GRAC: human AChR-alpha1 commonly used antagonist,CHEMBL,=,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
13304,valethamate,2800,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.56,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
13312,valproic acid,2803,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,4.21,,IC50,Inhibition of human recombinant HDAC2,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:4853
13339,varenicline,2808,Acetylcholine receptor; alpha1/beta1/delta/gamma,Ion channel,P02708|P07510|P11230|Q07001,CHRNA1|CHRNG|CHRNB1|CHRND,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHD_HUMAN,5.09,,Ki,Binding affinity to alpha-1-beta-gamma-delta nicotinic receptor,CHEMBL,=,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
13367,vecuronium,2811,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.824,,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200629,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
13370,vecuronium,2811,Acetylcholine receptor; alpha1/beta1/delta/gamma,Ion channel,P02708|P07510|P11230|Q07001,CHRNA1|CHRNG|CHRNB1|CHRND,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.09,,IC50,GRAC: human AChR-alpha1 commonly used antagonist,CHEMBL,=,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
13396,verapamil,2815,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,6.0,,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6966,BLOCKER,Tclin,Homo sapiens,HGNC:1390
13402,verapamil,2815,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,Q13698,CACNA1S,CAC1S_HUMAN,,,,,UNKNOWN,,1.0,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2406,BLOCKER,Tclin,Homo sapiens,HGNC:1397
13415,verapamil,2815,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P22002,Cacna1c,CAC1C_RAT,7.41,,IC50,Ability to inhibit [3H]nitrendipine binding to the L-type calcium channel receptor(CCR) in rat heart homogenate.,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2245
13416,verapamil,2815,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,Q02485,Cacna1s,CAC1S_RAT,7.24,,Ki,Inhibition of [3H]D-888 binding to L-type [Ca2+] channel of membranes from rat skeletal muscle,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:70983
13420,verapamil,2815,Voltage-gated L-type calcium channel,Ion channel,P22002|P27732|Q02485,Cacna1c|Cacna1d|Cacna1s,CAC1C_RAT|CAC1D_RAT|CAC1S_RAT,8.43,,IC50,Ability to inhibit [3H]nitrendipine binding to the calcium channel receptor(CCR) in rat cerebral cortex homogenate.,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2245
13457,vinburnine,2824,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.1,,Kd,,IUPHAR,=,,,,,ALLOSTERIC MODULATOR,Tclin,Homo sapiens,HGNC:1950
13505,nicotinic acid,2835,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,4.88,,IC50,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,CHEMBL,=,,,,,,,Homo sapiens,HGNC:620
13645,ziprasidone,2865,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.55,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
13777,zotepine,2875,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.745,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
13813,suramin,2966,NAD-dependent protein deacetylase sirtuin-2,Enzyme,Q8IXJ6,SIRT2,SIR2_HUMAN,5.96,,IC50,Inhibition of recombinant SIRT2 using ZMAL substrate after 4 hrs by homogeneous fluorescence assay,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:10886
13839,doxacurium,2974,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237099,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
13852,glucagon,2994,Adenylate cyclase,Enzyme,D4A3N4|P21932|P26769|P26770|P40146|Q03343|Q04400|Q8CFM9,Adcy1|Adcy3|Adcy2|Adcy4|Adcy8|Adcy6|Adcy5,D4A3N4_RAT|ADCY3_RAT|ADCY2_RAT|ADCY4_RAT|ADCY8_RAT|ADCY6_RAT|ADCY5_RAT|Q8CFM9_RAT,8.23,,EC50,Adenylate cyclase activity measured as 50% inhibitory concentration,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:1309318
13883,benzethonium,3018,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.004,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
13899,bietamiverine,3025,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.57,,Ki,Displacement of [3H] N-methylscopolamine from human muscarinic M1 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
14004,eburnamonine,3170,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.1,,Kd,,IUPHAR,=,,,,,ALLOSTERIC MODULATOR,Tclin,Homo sapiens,HGNC:1950
14021,enoxolone,3178,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,4.34,,IC50,Inhibition of recombinant PTP1B,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:9642
14086,evans blue,3217,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,5.89,,IC50,Inhibition of human PTPase 1B,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:9642
14099,femoxetine,3220,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.0360000000000005,,Ki,,PDSP,,,,,,,Tclin,Homo sapiens,HGNC:1950
14117,furtrethonium,3256,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,4.1,,Ki,,IUPHAR,=,,,,,AGONIST,Tclin,Homo sapiens,HGNC:1950
14181,iloperidone,3294,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.31,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
14285,oxiconazole,3408,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.943,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
14402,quercetin,3514,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,4.63,,IC50,The inhibitory activity tested against human Protein-tyrosine phosphatase 1B enzyme,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:9642
14403,quercetin,3514,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.92,,IC50,Inhibition of SRC (unknown origin),CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
14419,quercetin,3514,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,5.92,,IC50,Inhibition of FAK (unknown origin),CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:9611
14478,quercetin,3514,Proteasome subunit beta type-5,Enzyme,P28074,PSMB5,PSB5_HUMAN,5.7,,IC50,Inhibition of chymotrypsin-like activity of human 26S proteasome in human Jurkat cells assessed as decrease in AMC hydrolysis using Z-Gly-Gly-Leu-AMC as substrate after 24 hrs by fluorescence based method,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:9542
14508,quercetin,3514,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,5.1,,IC50,Inhibition of amyloid beta (1 to 42) aggregation (unknown origin),CHEMBL,=,,,,,,,Homo sapiens,HGNC:620
14516,quercetin,3514,Proteasome subunit beta type-5,Enzyme,P28074,PSMB5,PSB5_HUMAN,5.7,,IC50,Inhibition of chymotrypsin-like activity of human 26S proteasome in human Jurkat cells assessed as decrease in AMC hydrolysis using Z-Gly-Gly-Leu-AMC as substrate after 24 hrs by fluorescence based method,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:9542
14520,rapacuronium,3520,Muscle-type nicotinic acetylcholine receptor,Ion channel,P02708|P07510|P11230|Q04844|Q07001,CHRNA1|CHRNG|CHRNB1|CHRNE|CHRND,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHE_HUMAN|ACHD_HUMAN,,,,Mechanism of Action; CHEMBL2362997; PROTEIN COMPLEX GROUP,CHEMBL,,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/8680742,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
14563,ruboxistaurin,3533,Serine/threonine-protein kinase MARK2,Kinase,Q7KZI7,MARK2,MARK2_HUMAN,5.64,,Kd,Average Binding Constant for MARK2; NA=Not Active at 10 uM,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:3332
14681,sabcomeline,3536,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.77,,IC50,In vitro affinity against human Muscarinic acetylcholine receptor M1 using quinuclidynyl benzylate (QNB),CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
14686,sabcomeline,3536,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,7.85,,IC50,In vitro affinity evaluated using [3H]- oxotremorine as radioligand in rat cerebral cortex for muscarinic acetylcholine receptor,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
14800,vincamine,3643,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,4.8,,Kd,,IUPHAR,=,,,,,ALLOSTERIC MODULATOR,Tclin,Homo sapiens,HGNC:1950
14814,xanomeline,3652,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.38,,Ki,Affinity towards human M1 receptor expressed in CHO cells using [3H]QNB as radioligand,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
14825,xanomeline,3652,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.7,,IC50,Binding affinity for muscarinic acetylcholine receptor M1 using [3H]oxotremorine-M (Oxo-M) radioligand in rat hippocampus membranes,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
14826,xanomeline,3652,Muscarinic acetylcholine receptor M1,GPCR,P12657,Chrm1,ACM1_MOUSE,5.24,,EC50,Tested against Muscarinic acetylcholine receptor M1 expressed in A9 L cell line,CHEMBL,=,,,,,,,Mus musculus,MGI:88396
14827,xanomeline,3652,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,8.01,,IC50,Binding affinity against muscarinic receptor in rat brain membranes using oxotremorine-M as ligand,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
14865,yohimbine,3659,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P22002,Cacna1c,CAC1C_RAT,7.35,,Ki,Inhibition of [3H]nitrendipine binding to membrane homogenates of rat cardiac muscle.,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2245
14874,yohimbine,3659,Dual specificity phosphatase Cdc25A,Enzyme,P30304,CDC25A,MPIP1_HUMAN,4.65,,IC50,Inhibition of His-tagged Cdc25A expressed in the Escherichia coli BL21(DE3) using p-nitrophenyl phosphate as substrate for 80 mins by spectrophotometry,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:1725
14932,benidipine,3880,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,5.31,,IC50,"Inhibition of human L-type calcium channel Ca<sub>v</sub>1.2 in <i>Xenopus</i> oocyte, measured using 2-electrode voltage-clamp.",IUPHAR,=,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/17276408,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
15006,ivermectin,3972,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.9239999999999995,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
15081,levamlodipine,4099,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/17213004,https://pubmed.ncbi.nlm.nih.gov/17213004,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
15137,asenapine,4115,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.107,,Ki,,PDSP,,,,,,,Tclin,Homo sapiens,HGNC:1950
15159,pazopanib,4118,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.55,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
15183,pazopanib,4118,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.05,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:6735
15261,romidepsin,4119,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,7.3279999999999985,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:4853
15292,vorinostat,4124,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,8.8,,Ki,Inhibition of human HDAC2,CHEMBL,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,INHIBITOR,Tclin,Homo sapiens,HGNC:4853
15316,vorinostat,4124,Histone deacetylase,Enzyme,B1WBY8|Q4QQW4|Q5RJZ2|Q6P6W3|Q99P96|Q99P97|Q99P99,Hdac2|Hdac1|Hdac5|Hdac3|Hdac7|Hdac6|Hdac4,B1WBY8_RAT|HDAC1_RAT|Q5RJZ2_RAT|HDAC3_RAT|HDAC7_RAT|Q99P97_RAT|HDAC4_RAT,6.78,,IC50,Inhibitory concentration against rat liver Histone deacetylase,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:619976
15370,gentian violet,4138,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.577999999999999,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
15422,lercanidipine,4157,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/8821512,https://pubmed.ncbi.nlm.nih.gov/8821512,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
15484,linagliptin,4175,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.53,,IC50,Displacement of [N-methyl-3H]scopolamine from human recombinant muscarinic M1 receptor expressed in CHO cells,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
15503,vandetanib,4178,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,7.15,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,,,INHIBITOR,Tclin,Homo sapiens,HGNC:11283
15525,vandetanib,4178,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.96,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:6735
15644,crizotinib,4187,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.25,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
15657,crizotinib,4187,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,6.51,,Kd,Binding constant for FAK kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:9611
15667,crizotinib,4187,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.03,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:6735
15824,ruxolitinib,4190,Serine/threonine-protein kinase MARK2,Kinase,Q7KZI7,MARK2,MARK2_HUMAN,6.18,,Kd,Binding constant for MARK2 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:3332
15872,ruxolitinib,4190,Serine/threonine-protein kinase PAK 7,Kinase,Q9P286,PAK5,PAK5_HUMAN,5.89,,Kd,Binding constant for PAK7 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:15916
15878,ruxolitinib,4190,Serine/threonine-protein kinase PAK 4,Kinase,O96013,PAK4,PAK4_HUMAN,5.8,,Kd,Binding constant for PAK4 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:16059
15936,fesoterodine,4191,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.393,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
16106,axitinib,4225,Serine/threonine-protein kinase PAK 4,Kinase,O96013,PAK4,PAK4_HUMAN,5.35,,Kd,Binding constant for PAK4 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:16059
16196,Florbetapir F-18,4285,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,8.54,,Ki,,CHEMBL,=,,,,,,,Homo sapiens,HGNC:620
16214,Flutemetamol (18F),4301,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,9.15,,Ki,Binding affinity to human amyloid beta plaque,CHEMBL,=,,,,,,,Homo sapiens,HGNC:620
16215,glycopyrronium bromide,4302,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.69,,Ki,,SCIENTIFIC LITERATURE,=,1.0,CHEMBL,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002430/WC500133771.pdf,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201027,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
16250,aceclidine,4314,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.0,,EC50,,IUPHAR,=,,,,,AGONIST,Tclin,Homo sapiens,HGNC:1950
16255,aceclidine,4314,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,6.92,,IC50,Binding affinity for muscarinic acetylcholine receptor M1 using [3H]oxotremorine-M (Oxo-M) radioligand in rat hippocampus membranes,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
16256,aceclidine,4314,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,5.08,,Ki,"Binding affinity against muscarinic acetylcholine receptor from rat brain crude membrane, using [3H]-NMS (N-Methylscopolamine) as the radioligand.",CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
16262,afatinib,4318,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.55,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
16345,bosutinib,4359,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,9.0,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,INHIBITOR,Tclin,Homo sapiens,HGNC:11283
16359,bosutinib,4359,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,6.24,,Kd,Binding constant for FAK kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:9611
16374,bosutinib,4359,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,8.38,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,INHIBITOR,Tclin,Homo sapiens,HGNC:6735
16437,bosutinib,4359,Serine/threonine-protein kinase PAK 3,Kinase,O75914,PAK3,PAK3_HUMAN,5.24,,Kd,Binding constant for PAK3 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:8592
16481,bosutinib,4359,Serine/threonine-protein kinase PAK 1,Kinase,Q13153,PAK1,PAK1_HUMAN,5.64,,Kd,Binding constant for PAK1 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:8590
16482,bosutinib,4359,Serine/threonine-protein kinase PAK 2,Kinase,Q13177,PAK2,PAK2_HUMAN,5.72,,Kd,Binding constant for PAK2 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:8591
16629,dexchlorpheniramine,4411,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.478,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
16715,carfilzomib,4483,Proteasome subunit beta type-5,Enzyme,P28074,PSMB5,PSB5_HUMAN,8.222000000000001,,IC50,fluorogenic peptide substrate hydrolysis,SCIENTIFIC LITERATURE,=,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/17616698,https://pubmed.ncbi.nlm.nih.gov/17616698,INHIBITOR,Tclin,Homo sapiens,HGNC:9542
16716,aclidinium bromide,4484,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,10.1,,Ki,Binding affinity to muscarinic M1 receptor,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
16802,trypan blue,4608,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,5.41,,IC50,Inhibition of human PTPase 1B,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:9642
16846,trabectedin,4633,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.68,,IC50,Inhibition of Src,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
16897,methylatropine,4660,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.6,,Kd,In vitro receptor binding against Muscarinic acetylcholine receptor M1 in rat cerebral cortex was determined using [3H]pirenzepine,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
16899,methylatropine,4660,Muscarinic acetylcholine receptor DM1,GPCR,P16395,mAChR-A,ACM1_DROME,8.62,,Ki,,CHEMBL,=,,,,,,,Drosophila melanogaster,FlyBase:FBgn0000037
16906,betamethasone phosphate,4667,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.776,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
16937,panobinostat,4682,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,9.19,,Ki,Inhibition of human HDAC2,CHEMBL,=,1.0,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf,INHIBITOR,Tclin,Homo sapiens,HGNC:4853
17017,cabozantinib,4715,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.75,,IC50,"Inhibition of Src (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
17034,ponatinib,4716,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,8.52,,IC50,,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
17041,ponatinib,4716,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,9.62,,IC50,,WOMBAT-PK,=,,,,,INHIBITOR,Tclin,Homo sapiens,HGNC:6735
17045,ponatinib,4716,Proto-oncogene tyrosine-protein kinase Src,Kinase,P00523,SRC,SRC_CHICK,9.05,,IC50,Inhibition of chicken wild-type cSRC (251 to 533)-mediated phosphorylation of biotinylated poly-Glu-Tyr expressed in Escherichia coli BL21(DE3) preincubated for 30 to 60 mins prior to substrate addition by TR-FRET assay,CHEMBL,=,,,,,,,Gallus gallus,ENSEMBL:ENSGALG00000003855
17071,tenidap,4728,Inward rectifier potassium channel 4,Ion channel,P48050,KCNJ4,KCNJ4_HUMAN,6.4,,EC50,,IUPHAR,=,,,,,ACTIVATOR,Tchem,Homo sapiens,HGNC:6265
17204,ibrutinib,4810,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,7.854,,Ki,measured in anti-IgM stimulated Ramos human B cell line,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/17154430,,,Tclin,Homo sapiens,HGNC:6735
17206,ibrutinib,4810,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,7.721,,IC50,,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/26641137,,INHIBITOR,Tclin,Homo sapiens,HGNC:11283
17233,umeclidinium,4816,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.796,,Ki,"radioligand binding assays in CHO cells expressing human M1, M2, or M3 receptors in a scintillation proximity assay with 0.5 nM [3H]-N-methyl scopolamine as the ligand",SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/19317446,,,Tclin,Homo sapiens,HGNC:1950
17241,florbetaben F18,4818,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,8.65,,Ki,,CHEMBL,=,,,,,,,Homo sapiens,HGNC:620
17311,ceritinib,4866,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.77,,IC50,Inhibition of TEL-fused SRC (unknown origin) by cell-based assay,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
17325,ceritinib,4866,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.08,,IC50,Inhibition of LYN (unknown origin) after 60 mins,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:6735
17362,belinostat,4876,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,9.07,,Ki,Inhibition of human HDAC2,CHEMBL,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,INHIBITOR,Tclin,Homo sapiens,HGNC:4853
17435,imidafenacin,4902,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.384,,Kb,,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/10428387,,,Tclin,Homo sapiens,HGNC:1950
17443,nintedanib,4903,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.24,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
17461,nintedanib,4903,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,6.68,,Kd,Binding constant for FAK kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:9611
17471,nintedanib,4903,Serine/threonine-protein kinase MARK2,Kinase,Q7KZI7,MARK2,MARK2_HUMAN,5.85,,Kd,Binding constant for MARK2 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:3332
17473,nintedanib,4903,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.03,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:6735
17541,nintedanib,4903,Serine/threonine-protein kinase PAK 3,Kinase,O75914,PAK3,PAK3_HUMAN,6.68,,Kd,Binding constant for PAK3 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:8592
17577,nintedanib,4903,Serine/threonine-protein kinase PAK 7,Kinase,Q9P286,PAK5,PAK5_HUMAN,5.89,,Kd,Binding constant for PAK7 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:15916
17596,nintedanib,4903,Serine/threonine-protein kinase PAK 2,Kinase,Q13177,PAK2,PAK2_HUMAN,5.48,,Kd,Binding constant for PAK2 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:8591
17597,nintedanib,4903,Serine/threonine-protein kinase PAK 4,Kinase,O96013,PAK4,PAK4_HUMAN,5.52,,Kd,Binding constant for PAK4 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:16059
17793,chidamide,4973,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,6.796,,IC50,HDAC enzyme inhibition assay using BSA substrate,SCIENTIFIC LITERATURE,=,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/22080169,https://pubmed.ncbi.nlm.nih.gov/22080169,INHIBITOR,Tclin,Homo sapiens,HGNC:4853
17976,ixazomib,5067,Proteasome subunit beta type-5,Enzyme,P28074,PSMB5,PSB5_HUMAN,8.469,,IC50,,SCIENTIFIC LITERATURE,=,1.0,DRUG LABEL,https://pubmed.ncbi.nlm.nih.gov/20160034,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208462lbl.pdf,INHIBITOR,Tclin,Homo sapiens,HGNC:9542
18073,eteplirsen,5182,exon 51 of dystrophin pre-mRNA,RNA,P11532,DMD,DMD_HUMAN,,,,Mechanism of Action,UNKNOWN,,1.0,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206488lbl.pdf,BINDING AGENT,Tclin,Homo sapiens,HGNC:2928
18106,apatinib,5211,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.276,,IC50,,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/21443688,,INHIBITOR,Tclin,Homo sapiens,HGNC:11283
18147,midostaurin,5231,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.92,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
18183,midostaurin,5231,Serine/threonine-protein kinase MARK2,Kinase,Q7KZI7,MARK2,MARK2_HUMAN,7.0,,Kd,Binding constant for MARK2 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:3332
18185,midostaurin,5231,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,5.38,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:6735
18250,midostaurin,5231,Serine/threonine-protein kinase PAK 3,Kinase,O75914,PAK3,PAK3_HUMAN,6.75,,Kd,Binding constant for full-length PAK3,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:8592
18298,midostaurin,5231,Serine/threonine-protein kinase PAK 1,Kinase,Q13153,PAK1,PAK1_HUMAN,5.7,,Kd,Binding affinity to PAK1,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:8590
18299,midostaurin,5231,Serine/threonine-protein kinase PAK 2,Kinase,Q13177,PAK2,PAK2_HUMAN,5.68,,Kd,Binding affinity to PAK2,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:8591
18389,neratinib,5252,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.39,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
18398,neratinib,5252,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,5.72,,Kd,Binding constant for FAK kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:9611
18405,neratinib,5252,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.09,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:6735
18459,neratinib,5252,Serine/threonine-protein kinase PAK 1,Kinase,Q13153,PAK1,PAK1_HUMAN,6.68,,Kd,Binding constant for PAK1 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:8590
18460,neratinib,5252,Serine/threonine-protein kinase PAK 2,Kinase,Q13177,PAK2,PAK2_HUMAN,7.1,,Kd,Binding constant for PAK2 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:8591
18514,acalabrutinib,5260,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.0,,EC50,,IUPHAR,=,,,,,INHIBITOR,Tclin,Homo sapiens,HGNC:6735
18589,dacomitinib,5297,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.96,,IC50,Inhibition of Src (unknown origin),CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
18600,lorlatinib,5302,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,7.77,,IC50,,SCIENTIFIC LITERATURE,=,1.0,DRUG LABEL,https://pubmed.ncbi.nlm.nih.gov/25733882,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf,INHIBITOR,Tclin,Homo sapiens,HGNC:9611
18609,revefenacin,5303,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.38,,Ki,,SCIENTIFIC LITERATURE,=,1.0,DRUG LABEL,https://pubmed.ncbi.nlm.nih.gov/29736245,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210598s000lbl.pdf,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
18673,selinexor,5330,Exportin-1,Nuclear other,O14980,XPO1,XPO1_HUMAN,7.7,,IC50,Mechanism of Action,SCIENTIFIC LITERATURE,=,1.0,DRUG LABEL,https://clinicaltrials.gov/ProvidedDocs/61/NCT02215161/Prot_SAP_000.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212306s000lbl.pdf,INHIBITOR,Tclin,Homo sapiens,HGNC:12825
18697,quizartinib,5341,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,5.24,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:6735
18742,entrectinib,5345,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,6.85,,IC50,Inhibition of FAK (unknown origin) in presence of gamma33-ATP,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:9611
18762,fedratinib,5347,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,7.12,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
18784,fedratinib,5347,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,7.38,,Kd,Binding constant for FAK kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:9611
18800,fedratinib,5347,Serine/threonine-protein kinase MARK2,Kinase,Q7KZI7,MARK2,MARK2_HUMAN,5.51,,Kd,Binding constant for MARK2 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:3332
18802,fedratinib,5347,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.3,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:6735
18924,fedratinib,5347,Serine/threonine-protein kinase PAK 7,Kinase,Q9P286,PAK5,PAK5_HUMAN,5.92,,Kd,Binding constant for PAK7 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:15916
18944,fedratinib,5347,Serine/threonine-protein kinase PAK 1,Kinase,Q13153,PAK1,PAK1_HUMAN,5.51,,Kd,Binding constant for PAK1 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:8590
18945,fedratinib,5347,Serine/threonine-protein kinase PAK 2,Kinase,Q13177,PAK2,PAK2_HUMAN,5.22,,Kd,Binding constant for PAK2 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:8591
18946,fedratinib,5347,Serine/threonine-protein kinase PAK 4,Kinase,O96013,PAK4,PAK4_HUMAN,5.42,,Kd,Binding constant for PAK4 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:16059
19063,golodirsen,5357,exon 53 of dystrophin pre-mRNA,RNA,P11532,DMD,DMD_HUMAN,,,,Mechanism of Action,UNKNOWN,,1.0,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211970s000lbl.pdf,ANTISENSE INHIBITOR,Tclin,Homo sapiens,HGNC:2928
19075,brilliant Blue G,5359,Alpha-synuclein,Transporter,P37840,SNCA,SYUA_HUMAN,5.27,,IC50,Inhibition of wild type alpha-synuclein (unknown origin) aggregation expressed in Escherichia coli BL21 after 30 days by thioflavin T staining-based spectrofluorimetric analysis,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:11138
19169,oliceridine,5406,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,4.44,,IC50,Inhibition of human Cav 1.2 ion channel expressed in HEK293 cells by whole-cell patch clamp technique,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1390
19171,oliceridine,5406,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,4.44,,IC50,Inhibition of human Cav 1.2 ion channel expressed in HEK293 cells by whole-cell patch clamp technique,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1390
19175,viltolarsen,5408,exon 53 of dystrophin pre-mRNA,RNA,P11532,DMD,DMD_HUMAN,8.33,,EC50,Activity determined in rhabdomyosarcoma cells isolated from DMD patients,DRUG LABEL,=,1.0,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/212154Orig1s000PharmR.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212154Orig1s000lbl.pdf,BINDING AGENT,Tclin,Homo sapiens,HGNC:2928
19258,tirbanibulin,5431,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,4.34,,IC50,Low affinity is expected because the peptide substrate binding site is not well formed when Src is isolated.,IUPHAR,=,,,,,INHIBITOR,Tclin,Homo sapiens,HGNC:11283
19259,tirbanibulin,5431,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,7.0,,IC50,Inhibition of LYN (unknown origin),CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:6735
19260,tirbanibulin,5431,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,4.34,,IC50,Low affinity is expected because the peptide substrate binding site is not well formed when Src is isolated.,IUPHAR,=,,,,,INHIBITOR,Tclin,Homo sapiens,HGNC:11283
19261,tirbanibulin,5431,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,7.0,,IC50,Inhibition of LYN (unknown origin),CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:6735
19293,casimersen,5443,exon 53 of dystrophin pre-mRNA,RNA,P11532,DMD,DMD_HUMAN,,,,Mechanism of Action,UNKNOWN,,1.0,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213026lbl.pdf,ANTISENSE INHIBITOR,Tclin,Homo sapiens,HGNC:2928
19314,infigratinib,5459,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.53,,IC50,Inhibition of SRC-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
19330,infigratinib,5459,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.52,,IC50,Inhibition of recombinant LYN kinase,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:6735
19339,infigratinib,5459,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.53,,IC50,Inhibition of SRC-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
19347,infigratinib,5459,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.52,,IC50,Inhibition of recombinant LYN kinase,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:6735
19352,infigratinib,5459,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.53,,IC50,Inhibition of SRC-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
